Report #2862019

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 9 yrs
State: CA
Recovered: Unknown
Vaccinated: Sep 23, 2025
Onset: Sep 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	Y013768	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No adverse effects reported; patient received her 2nd dose of GARDASIL 9 too early; This spontaneous report was received from a Certified Medical Assistant (CMA) and refers to a 9-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. The CMA reported the patient received her 2nd 0.5ml dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y013768, expiration date: 12-Feb-2025), too early. Patient received it on 23-Sep-2025 instead of 06-Nov-2025. No adverse effects were reported. At the reporting time, the outcome of patient received her 2nd dose of GARDASIL 9 too early and No adverse effects reported was unknown. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant was determined as not applicable.